|
ALKBH1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.949700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.200200E-02 |
| Normal-vs-Stage2 |
7.795400E-01 |
| Normal-vs-Stage3 |
6.554000E-01 |
| Normal-vs-Stage4 |
3.486200E-01 |
| Stage1-vs-Stage2 |
3.893200E-01 |
| Stage1-vs-Stage3 |
3.519400E-01 |
| Stage1-vs-Stage4 |
9.088800E-01 |
| Stage2-vs-Stage3 |
9.585400E-01 |
| Stage2-vs-Stage4 |
5.679200E-01 |
| Stage3-vs-Stage4 |
5.315600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.334400E-02 |
| Normal-vs-AfricanAmerican |
1.680180E-01 |
| Normal-vs-Asian |
8.725200E-01 |
| Caucasian-vs-AfricanAmerican |
8.358400E-01 |
| Caucasian-vs-Asian |
3.743600E-01 |
| AfricanAmerican-vs-Asian |
4.928000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.084000E-02 |
| Normal-vs-Female |
2.687200E-01 |
| Male-vs-Female |
6.252000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.096200E-02 |
| Normal-vs-Extreme_Weight |
7.061600E-03 |
| Normal-vs-Obese |
2.731000E-01 |
| Normal-vs-Extreme_Obese |
7.281000E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.470200E-01 |
| Normal_Weight-vs-Obese |
4.401800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.934200E-01 |
| Extreme_Weight-vs-Obese |
2.956800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.114600E-01 |
| Obese-vs-Extreme_Obese |
9.201400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.333600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.682400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.335310E-03 |
| Normal-vs-Age(81-100Yrs) |
1.121760E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.680000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.549900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.854180E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.407630E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.560200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.799400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.617600E-02 |
| Normal-VS-Type2 PRCC |
7.638400E-02 |
| Normal-VS-KIRP CIMP |
7.771600E-01 |
| Normal-VS-Unclassified PRCC |
2.877800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.950400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.157000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.408400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.821400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.334400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.229400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.510000E-02 |
| Normal-vs-N1 |
8.768200E-01 |
| Normal-vs-N2 |
6.12919999999351E-05 |
| N0-vs-N1 |
1.112020E-01 |
| N0-vs-N2 |
6.345500E-02 |
| N1-vs-N2 |
3.626400E-02 |
|
|
